Comment on "Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positive NSCLC: Real-World Outcomes From the GuardantINFORM Database".

J Thorac Oncol

Department of Research, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People's Republic of China; Department of Pharmacy, Dongying People's Hospital, Dongying, People's Republic of China. Electronic address:

Published: November 2024

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jtho.2024.07.023	DOI Listing

Publication Analysis

Top Keywords

comment "impact

"impact eml4-alk

eml4-alk variants

variants co-occurring

co-occurring tp53

tp53 mutations

mutations duration

duration first-line

first-line alk

alk tyrosine

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!